Neogen (NEOG) Non Operating Income (2010 - 2026)
Neogen's (NEOG) quarterly Non Operating Income came in at -$17.0 million in Q1 2026, down 12.58% year-on-year from -$19.4 million in Q1 2025, and down 13.43% quarter-over-quarter from -$15.0 million in Q4 2025.
Neogen (NEOG) Non Operating Income (2010 - 2026) Analysis & Trends
Neogen's Non Operating Income history runs 17 years deep, the most recent figure standing at -$17.0 million for Q1 2026.
- On a quarterly basis, Non Operating Income fell 12.58% year-over-year to -$17.0 million in Q1 2026; TTM through Feb 2026 was $7.9 million, a 111.05% increase from a year earlier, with the FY2025 full-year figure at -$72.1 million, up 1.17% from the prior year.
- Non Operating Income declined to -$17.0 million in Q1 2026 per NEOG's latest filing, from -$15.0 million in the prior quarter.
- Across five years, Non Operating Income topped out at $59.9 million in Q3 2025 and bottomed at -$26.4 million in Q4 2022.
- The 5-year median for Non Operating Income is -$17.5 million (2023), against an average of -$10.3 million.
- Across the five-year window, Non Operating Income soared 3416.67% in 2022 and slumped 6845.86% in 2023, its largest moves.
- Year by year, Non Operating Income stood at -$26.4 million in 2022, then soared by 31.11% to -$18.2 million in 2023, then retreated by 4.81% to -$19.1 million in 2024, then rose by 21.48% to -$15.0 million in 2025, then declined by 13.43% to -$17.0 million in 2026.
- Per Business Quant, the three latest NEOG Non Operating Income figures stand at -$17.0 million (Q1 2026), -$15.0 million (Q4 2025), and $59.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.06 Bn | 175.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.66 Bn | 125.78 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.29 Bn | 44.61 Bn | 1.29 Bn | -18.60 Mn |
| 6 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn | - |
| 7 | Dexcom | 28.29 Bn | 27.18 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | - |
| 10 | Neogen | 2.06 Bn | 1.90 Bn | 99.00 Mn | -17.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -17.00 Mn |
| Nov 30, 2025 | -14.99 Mn |
| Aug 31, 2025 | 59.90 Mn |
| May 31, 2025 | -20.01 Mn |
| Feb 28, 2025 | -15.10 Mn |
| Nov 30, 2024 | -19.09 Mn |
| Aug 31, 2024 | -17.87 Mn |
| May 31, 2024 | -19.44 Mn |
| Feb 29, 2024 | -17.85 Mn |
| Nov 30, 2023 | -18.21 Mn |
| Aug 31, 2023 | -17.47 Mn |
| May 31, 2023 | -15.78 Mn |
| Feb 28, 2023 | -17.94 Mn |
| Nov 30, 2022 | -26.44 Mn |
| Aug 31, 2022 | 597,000.00 |
| May 31, 2022 | 632,000.00 |
| Feb 28, 2022 | 266,000.00 |
| Nov 30, 2021 | 459,000.00 |
| Aug 31, 2021 | -18,000.00 |
| May 31, 2021 | 484,000.00 |